The 20 Best Leydig Cell Hypoplasia Doctors Near Me in Michigan, US
Find the Top Leydig Cell Hypoplasia Experts and Specialists
C. S. Mott Children's Hospital
Dr. Shumer is an Associate Professor in the Department of Pediatric Endocrinology. He received his bachelor's degree from Northwestern University and his medical degree from the Feinberg School of Medicine at Northwestern University. He completed his Pediatric Residency at Vermont Children’s Hospital at the University of Vermont, where he also served as Chief Resident. Dr. Shumer then completed fellowship training in Pediatric Endocrinology at Boston Children’s Hospital and concurrently completed a Masters of Public Health at Harvard T. H. Chan School of Public Health. Dr. Shumer is rated as an Advanced provider by MediFind in the treatment of Leydig Cell Hypoplasia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Leydig Cell Hypoplasia, Congenital Adrenal Hyperplasia (CAH), Type 1 Diabetes (T1D), and Mosaicism. Dr. Shumer is board certified in Pediatric Endocrinology and Pediatrics.
C. S. Mott Children's Hospital
Mark Hannibal is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Hannibal is rated as an Advanced provider by MediFind in the treatment of Leydig Cell Hypoplasia. He is also highly rated in 166 other conditions, according to our data. His clinical expertise encompasses Aase Syndrome, CHARGE Syndrome, Cockayne Syndrome Type 2, and Hennekam Syndrome. Dr. Hannibal is board certified in Clinical Genetics & Genomics.
Von Voigtlander Women's Hospital
Dr. Dendrinos is an Assistant Professor in the Department of Obstetrics and Gynecology. She received her medical degree from Case Western Reserve School of Medicine in 2004 and then completed her residency in Obstetrics and Gynecology at the University of Chicago. She returned to Ann Arbor to complete a fellowship in Pediatric and Adolescent Gynecology at the University of Michigan.She is board-certified in Obstetrics and Gynecology, in addition to being certified for Pediatric & Adolescent Gynecology Focused Practice.Dr. Dendrinos is committed to providing quality medical and surgical care for women of all ages for a range of benign gynecologic conditions. She has special interest and training in the gynecologic issues of girls and young women.Dr. Dendrinos’s clinical activities include:Pediatric and adolescent gynecology: girls from 0-21 with reproductive health concerns and congenital anomalies.DSD care: Dr. Dendrinos is a provider in the University of Michigan Clinical Center for Disorders/Differences of Sex Development (DSD). Here specific expertise within the team is related to the reproductive and gynecological aspects, both medically and surgically, of girls and women with DSD.Adult gynecology care: Her adult clinic focuses on abnormal bleeding issues in women of all ages with a special interest in hysterectomy alternatives. Dr. Dendrinos is rated as an Advanced provider by MediFind in the treatment of Leydig Cell Hypoplasia. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Vaginal Agenesis, Kuster Syndrome, Hydrocele, Painful Menstrual Periods, and Intrauterine Device Insertion. Dr. Dendrinos is board certified in Obstetrics & Gynecology.
C. S. Mott Children's Hospital
Dr. Kraft is clinical associate professor in the Department of Urology at the University of Michigan and practices pediatric urology at C.S. Mott Children’s Hospital in Ann Arbor.She received her undergraduate degree from Harvard University and medical degree from Columbia University College of Physicians & Surgeons. She pursued her urology residency at Emory University School of Medicine in Atlanta, GA and then completed a fellowship in pediatric urology at the Children’s Hospital of Philadelphia. Dr. Kraft’s clinical interests include minimally invasive surgery and endourology in children, pediatric andrology, and disorders of sex development. She is currently pursuing clinical research in pediatric stone disease, uroradiology, spina bifida, and adolescent varicocele. With her interest in graduate medical education, Dr. Kraft serves as the Urology Residency Program Director and oversees urology postgraduate training at the University of Michigan. Dr. Kraft is rated as an Advanced provider by MediFind in the treatment of Leydig Cell Hypoplasia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Undescended Testicle, Posterior Urethral Valves, Hypospadias, Lithotripsy, and Ureteroscopy.
U Of M Radiology
David Bloom is a Radiologist and a Pediatric Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Bloom is rated as an Experienced provider by MediFind in the treatment of Leydig Cell Hypoplasia. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, PIK3CA-Related Overgrowth Spectrum, Atresia of Small Intestine, and Parkes Weber Syndrome. Dr. Bloom is board certified in Diagnostic Radiology and Pediatric Radiology.
University Of Michigan Medical Center
Ming Chen is a Pediatric Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Leydig Cell Hypoplasia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Leydig Cell Hypoplasia, Adrenal Insufficiency Pediatric, and Congenital Hypothyroidism.
U Of M Obstetrics & Gynecology
Erin Isaacson is an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Isaacson is rated as an Experienced provider by MediFind in the treatment of Leydig Cell Hypoplasia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Menorrhagia, Leydig Cell Hypoplasia, Pelvic Congestion Syndrome, and Ectopic Pregnancy. Dr. Isaacson is board certified in Obstetrics & Gynecology.
Last Updated: 04/28/2026



